embecta to Participate in Investor Events
Embecta Corp. (EMBC), a global diabetes care company, has announced its participation in two upcoming investor events. The company will attend the 2024 Wells Fargo Healthcare Conference on September 4, hosting one-on-one investor meetings at the Encore Boston Harbor Hotel. Additionally, embecta will participate in the 2024 Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, where management will host a fireside session at 2:35 p.m. ET at the Marriott Marquis in New York.
These events provide opportunities for investors to engage with embecta's management and gain insights into the company's operations and strategy. Audio webcasts of the presentations will be available on embecta's investor relations website under the 'News & Events' section, allowing wider access to the company's updates and discussions.
Embecta Corp. (EMBC), un'azienda globale nel settore della cura del diabete, ha annunciato la sua partecipazione a due eventi per investitori in arrivo. L'azienda parteciperà al 2024 Wells Fargo Healthcare Conference il 4 settembre, ospitando riunioni individuali con gli investitori presso l'Encore Boston Harbor Hotel. Inoltre, embecta parteciperà al 2024 Morgan Stanley 22° Annual Global Healthcare Conference il 5 settembre, dove la direzione ospiterà una sessione informale alle 14:35 ET presso il Marriott Marquis di New York.
Questi eventi offrono opportunità per gli investitori di interagire con il management di embecta e ottenere informazioni sulle operazioni e sulla strategia dell'azienda. Le dirette audio delle presentazioni saranno disponibili sul sito web delle relazioni con gli investitori di embecta nella sezione 'News & Events', consentendo un accesso più ampio agli aggiornamenti e alle discussioni dell'azienda.
Embecta Corp. (EMBC), una empresa global de atención para la diabetes, ha anunciado su participación en dos eventos de inversores próximos. La compañía asistirá a la 2024 Wells Fargo Healthcare Conference el 4 de septiembre, organizando reuniones individuales con inversores en el Encore Boston Harbor Hotel. Adicionalmente, embecta participará en la 2024 Morgan Stanley 22ª Conferencia Anual Global de Atención Médica el 5 de septiembre, donde la dirección llevará a cabo una sesión informal a las 2:35 p.m. ET en el Marriott Marquis de Nueva York.
Estos eventos brindan oportunidades para que los inversores se conecten con la dirección de embecta y obtengan información sobre las operaciones y la estrategia de la empresa. Las transmisiones de audio de las presentaciones estarán disponibles en el sitio web de relaciones con inversores de embecta en la sección 'News & Events', permitiendo un acceso más amplio a las actualizaciones y discusiones de la empresa.
엠벡타 코퍼레이션 (EMBC), 글로벌 당뇨병 관리 회사가 두 가지 투자자 이벤트에 참여한다고 발표했습니다. 회사는 9월 4일 2024 웰스 파고 헬스케어 컨퍼런스에 참석하며, Encore Boston Harbor Hotel에서 일대일 투자자 회의를 진행합니다. 또한, 엠벡타는 9월 5일 2024 모건 스탠리 제22회 글로벌 헬스케어 컨퍼런스에 참여하여, 오후 2시 35분(동부 표준시)에 뉴욕의 Marriott Marquis에서 화로 세션을 주최합니다.
이 이벤트들은 투자자들이 엠벡타 경영진과 교류하고 회사의 운영 및 전략에 대한 통찰을 얻을 수 있는 기회를 제공합니다. 프레젠테이션의 오디오 웹캐스트는 엠벡타의 투자자 관계 웹사이트 '뉴스 및 이벤트' 섹션에서 확인할 수 있어, 회사의 업데이트 및 논의에 대한 더 폭넓은 접근이 가능합니다.
Embecta Corp. (EMBC), une entreprise mondiale spécialisée dans les soins du diabète, a annoncé sa participation à deux événements pour investisseurs à venir. La société assistera à la 2024 Wells Fargo Healthcare Conference le 4 septembre, organisant des réunions individuelles avec les investisseurs à l'Encore Boston Harbor Hotel. De plus, embecta participera à la 2024 Morgan Stanley 22e Conférence Annuelle Mondiale sur les Soins de Santé le 5 septembre, où la direction animera une session informelle à 14h35 ET au Marriott Marquis de New York.
Ces événements offrent aux investisseurs des opportunités d'interagir avec la direction d'embecta et d'obtenir des informations sur les activités et la stratégie de l'entreprise. Des webcasts audio des présentations seront disponibles sur le site web des relations avec les investisseurs d'embecta dans la section 'News & Events', permettant un accès plus large aux mises à jour et aux discussions de l'entreprise.
Embecta Corp. (EMBC), ein globales Unternehmen im Bereich Diabetesversorgung, hat seine Teilnahme an zwei bevorstehenden Investorenevents angekündigt. Das Unternehmen wird am 4. September an der 2024 Wells Fargo Healthcare Conference teilnehmen und Einzelgespräche mit Investoren im Encore Boston Harbor Hotel führen. Darüber hinaus wird embecta am 5. September an der 2024 Morgan Stanley 22. Jahrestagung Global Healthcare Conference teilnehmen, wo das Management um 14:35 Uhr ET im Marriott Marquis in New York eine informelle Sitzung leiten wird.
Diese Veranstaltungen bieten Investoren die Möglichkeit, mit dem Management von embecta in Kontakt zu treten und Einblicke in die Unternehmensabläufe und die Strategie zu gewinnen. Audio-Webcasts der Präsentationen werden im Bereich 'News & Events' auf der Investor-Relations-Website von embecta verfügbar sein, was einen breiteren Zugang zu den Unternehmensupdates und Diskussionen ermöglicht.
- None.
- None.
PARSIPPANY, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that management will participate in the following investor events:
2024 Wells Fargo Healthcare Conference
• | Management will host one-on-one investor meetings on Wednesday, September 4, 2024, at the Encore Boston Harbor Hotel in Boston. |
2024 Morgan Stanley 22nd Annual Global Healthcare Conference
• | Management will host a fireside session on Thursday, September 5, 2024, at 2:35 p.m. Eastern Time (ET) at the Marriott Marquis in New York. Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at https://investors.embecta.com. |
About embecta
embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships, and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, Instagram and Twitter.
Contacts:
Media | Investors |
Christian Glazar | Pravesh Khandelwal |
Sr. Director, Corporate Communications | VP, Head of Investor Relations |
908-821-6922 | 551-264-6547 |
Contact Media Relations | Contact IR |
FAQ
What investor events will embecta (EMBC) participate in during September 2024?
Where can investors access the audio webcasts of embecta's (EMBC) presentations at the investor events?
What type of meetings will embecta (EMBC) host at the 2024 Wells Fargo Healthcare Conference?